Cover Image
Market Research Report

Tissue Engineering Market - Growth, Trends, and Forecast (2020 - 2025)

Published by Mordor Intelligence LLP Product code 921273
Published Content info 113 Pages
Delivery time: 2-3 business days
Price
Back to Top
Tissue Engineering Market - Growth, Trends, and Forecast (2020 - 2025)
Published: January 1, 2020 Content info: 113 Pages
Description

Market Overview

The tissue engineering market will show rapid growth due to the increasing incidences of chronic diseases, road accidents, and trauma injuries, technological advancements in 3d tissue engineering and ongoing research for tissue regeneration.

The rising chronic diseases, road accidents, and trauma injuries are found to be contributing to the growth in the development of tissue engineering solutions. There is number of increasing people in need of bone implants that are on the rise owing to the increasing cases of chronic diseases, trauma cases, and growing average life span.

Furthermore, there is also a demand for relatively cheap and available skin-replacement products that have encouraged many research groups worldwide to focus on creating biomaterials for skin substitution. The engineered tissues not only closes wounds but also stimulates the regeneration of the dermis and would provide a significant benefit in human wound healing. Moreover, the increasing prevalence of chronic diseases alongside road accidents, injuries, and trauma cases escalates the market on the global platform.

There is also an increase in funding from government and private companies for R&D of regenerative treatments and growth in the adoption of the regenerative medicine industry that is expected to drive the overall market.

Scope of the Report

As per the scope of the report, tissue engineering is the use of a combination of cells, engineering, and other materials methods, and suitable biochemical and physicochemical factors to improve or replace the biological tissues. It is gaining traction in various areas such as wound care, burn treatment, orthopedics, neurology, urological products, and others. It also plays an important role in the management of pediatric patients.

Key Market Trends

Cardiology & Vascular is Expected to Show the Fastest Growth in the Application Type Segment During the Forecast Period

Cardiology and the vascular segment are likely to grow at the fastest rate in the coming years, due to the rapidly rising incidence rate of cardiovascular diseases and lifestyle changes. The rising number of replacement as well as reconstructive surgeries that have favored the industry growth. Despite various technological advancements in this field, cardiovascular disorders are one of the leading causes of death globally. There are advancements in tissue engineering also that are likely to boost the market growth.

Asia pacific has Recorded the Fastest Growth During the Forecast Period

Asia Pacific regional segment is expected to witness the fastest growth over the forecast period, due to the increasing demand for regenerative medicines. There is also growth in medical tourism that helps to accelerate market growth. Some of the major industry players are found entering the market in order to collaborate with these biotechnology companies to expand their regional presence.

Furthermore, the market is also increasing due to the rising biomaterial-based research, increasing demand for plastic surgeries, a growing number of cancer incidences and the increasing prevalence of cardiovascular diseases.

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to market growth. These companies' new product developments, mergers, and acquisitions are some of the strategies undertaken by these companies to strengthen their market presence. Also, there are many companies that are upgrading their product portfolios in order to meet the current demand.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support
Table of Contents
Product Code: 67609

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase Incidences of Chronic Diseases, Road Accidents, and Trauma Injuries
    • 4.2.2 Technological Advancements in 3D Tissue Engineering
    • 4.2.3 Increase in Funding and Research for Tissue Regeneration
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Treatments Related to Tissue Engineering
    • 4.3.2 Lack of Awareness Regarding Tissue Engineering
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Material
    • 5.1.1 Synthetic Materials
    • 5.1.2 Biologically Derived Materials
    • 5.1.3 Others
  • 5.2 By Application
    • 5.2.1 Orthopedics
    • 5.2.2 Musculoskeletal & Spine
    • 5.2.3 Neurology
    • 5.2.4 Cardiology & Vascular
    • 5.2.5 Skin & Integumentary
    • 5.2.6 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan Plc
    • 6.1.2 Integra Lifesciences
    • 6.1.3 C. R. Bard
    • 6.1.4 Zimmer Biomet
    • 6.1.5 Organogenesis
    • 6.1.6 Osiris Therapeutics
    • 6.1.7 Biotime Inc.
    • 6.1.8 B. Braun Melsungen AG
    • 6.1.9 Bio Tissue Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top